ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Molecular Characterization, Tumor Microenvironment Association, and Drug Susceptibility of DNA Methylation-Driven Genes in Renal Cell Carcinoma

Wang, Jinpeng; Zhang, Wei; Hou, Wenbin; Zhao, Enyang*; Li, Xuedong*哈尔滨医科大学
Frontiers in Cell and Developmental Biology2022-3-21DOI: 10.3389/fcell.2022.837919
3被引9阅读
引用收藏
分享

摘要

Accumulating evidence suggests that DNA methylation has essential roles in the development of renal cell carcinoma (RCC). Aberrant DNA methylation acts as a vital role in RCC progression through regulating the gene expression, yet little is known about the role of methylation and its association with prognosis in RCC. The purpose of this study is to explore the DNA methylation-driven genes for establishing prognostic-related molecular clusters and providing a basis for survival prediction. In this study, 5,198 differentially expressed genes (DEGs) and 270 DNA methylation-driven genes were selected to obtain 146 differentially expressed DNA methylation-driven genes (DEMDGs). Two clusters were distinguished by consensus clustering using 146 DEMDGs. We further evaluated the immune status of two clusters and selected 106 DEGs in cluster 1. Cluster-based immune status analysis and functional enrichment analysis of 106 DEGs provide new insights for the development of RCC. To predict the prognosis of patients with RCC, a prognostic model based on eight DEMDGs was constructed. The patients were divided into high-risk groups and low-risk groups based on their risk scores. The predictive nomogram and the web-based survival rate calculator () were built to validate the predictive accuracy of the prognostic model. Gene set enrichment analysis was performed to annotate the signaling pathways in which the genes are enriched. The correlation of the risk score with clinical features, immune status, and drug susceptibility was also evaluated. These results suggested that the prognostic model might be a promising prognostic tool for RCC and might facilitate the management of patients with RCC.

学科与关键词

关键词
renal cell carcinomamolecular characterizationmethylation-driven genestumor microenvironmentdrug susceptibility
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
Frontiers in Cell and Developmental Biology
发表日期
2022-03-21
卷期
第 10 卷
页码
837919
DOI
10.3389/fcell.2022.837919
期刊等级
3区
成果收录
SCIE
资助标注
Scientific Research Project of Heilongjiang Provincial Health and Family Planning Commission [2017-070]; Second Affiliated Hospital of Harbin Medical University First-class Discipline First-class Specialist Construction Project [100123]; Harbin Medical University Scientific Research Innovation Fund [YJSKYCX2018-95HYD]

作者

  • W

    Wang, Jinpeng (第一作者)

    2 · harbin med univ

  • Z

    Zhang, Wei

    2 · harbin med univ

查看全部 5 位作者收起作者
  • H

    Hou, Wenbin

    2 · harbin med univ

  • Z

    Zhao, Enyang (通讯)

    2 · harbin med univ

  • L

    Li, Xuedong (通讯)

    2 · harbin med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417